IMGN - ImmunoGen Inc. (IMGN) CEO Mark Enyedy on Q4 2019 Results - Earnings Call Transcript
ImmunoGen, Inc. (IMGN)
Q4 2019 Results Earnings Conference Call
February 14, 2020, 08:00 AM ET
Company Participants
Courtney O’Konek - Senior Director of Corporate Communications & IR
Mark Enyedy - President, CEO, Interim Principal Financial Officer
Anna Berkenblit - Senior VP & Chief Medical Officer
Theresa Wingrove - SVP of Regulatory Affairs & Quality
Dave Foster - Chief Accounting Officer
Conference Call Participants
John Newman - Canaccord
Biren Amin - Jefferies
Andy Hsieh - William Blair
Boris Peaker - Cowen
Jessica Fye - JPMorgan
David Ruch - SVB Leerink
Kennen MacKay - RBC Capital Markets